Author: Cross, Robert W.; Mire, Chad E.; Borisevich, Viktoriya; Geisbert, Joan B.; Fenton, Karla A.; Geisbert, Thomas W.
Title: The Domestic Ferret (Mustela putorius furo) as a Lethal Infection Model for 3 Species of Ebolavirus Document date: 2016_8_15
ID: 6nu7rob8_2
Snippet: NHPs have historically served as the gold standard for modeling filovirus pathogenesis because they recapitulate many features of human disease, including fever, vascular leakage, and coagulopathy, without the need for virus adaptation. Several immunocompetent small-animal models have been developed for ZEBOV, including mice, hamsters, and guinea pigs. However, all of these small-animal models require host adaptation of the challenge virus [1] . .....
Document: NHPs have historically served as the gold standard for modeling filovirus pathogenesis because they recapitulate many features of human disease, including fever, vascular leakage, and coagulopathy, without the need for virus adaptation. Several immunocompetent small-animal models have been developed for ZEBOV, including mice, hamsters, and guinea pigs. However, all of these small-animal models require host adaptation of the challenge virus [1] . Some severely immunodeficient models have been described, allowing the use of wild-type virus, but there are substantial limitations in the usefulness of these models in the development of countermeasures for circumstances in which dependency on an intact immune response is central [1, 2] . A further limitation is that only the NHP models account for the different species of Ebolavirus beyond ZEBOV, with the recent exception of guinea pig models of SEBOV [3, 4] .
Search related documents:
Co phrase search for related documents- challenge virus and guinea pig: 1, 2
- challenge virus and guinea pig hamster: 1
- challenge virus and guinea pig hamster mouse: 1
- challenge virus and host adaptation: 1
- challenge virus and human disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- challenge virus and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- challenge virus and NHP model: 1, 2
- challenge virus and small animal: 1, 2, 3, 4, 5, 6
- challenge virus and small animal model: 1, 2, 3, 4, 5, 6
- challenge virus and virus adaptation: 1, 2, 3, 4, 5
- challenge virus and wild type: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39
- challenge virus and wild type virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26
- coagulopathy vascular leakage and vascular leakage: 1
- coagulopathy vascular leakage fever and vascular leakage: 1
- countermeasure development and human disease: 1, 2, 3, 4, 5, 6
Co phrase search for related documents, hyperlinks ordered by date